Leading From Within with ISCT & Kiji's Miguel Forte, M.D.

Business Of Biotech

We love to hear from our listeners. Send us a message.

He's been a big pharma executive. He's a multi-time biotech founder and current biotech CEO. He was once a regulator. He's a physician. He serves on multiple boards. And as of this summer, he's president of one of the most influential global organizations dedicated to the advance of cell and gene therapies (ISCT), and an executive member of another (ARM). Miguel Forte, M.D. simply can't stop finding places to apply his talents and energy to influence the advanced therapies landscape. The experiences he's amassed give him a unique perspective on the industry's path forward, how to navigate the regulatory gauntlet, the role of industry associations and alliances in a biotech's succes, balancing the demands of multi-point leadership, changing the ATMP accesibility paradigm, and more. On this episode of the Business of Biotech, Dr. Forte shares generously on all of it.
Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.

Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: [e-mail]
Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/

Hoofdstukken

1. Leading From Within with ISCT & Kiji's Miguel Forte, M.D. (00:00:00)

2. Dr. Miguel Forte on Cell Therapy (00:00:03)

3. Enhancing Global Cell Therapy Access (00:16:20)

4. Navigating Regulatory Expectations in Biotech (00:29:57)

5. Navigating Regulatory Expectations in Biotech Leadership (00:35:21)

6. Balancing Leadership and Priorities in Biotech (00:49:21)